Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-01-28

Clinical Trial Update: Genitourinary and Pharyngeal Pharmacokinetics of Solithromycin [Phase 1]

View source ↗

Summary

Phase 1 study examining genitourinary and pharyngeal pharmacokinetics of solithromycin in gonorrhea; the trial is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solithromycin (solithromycin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Gonorrhoea | Phase 1 | Status: COMPLETED